As of 2024-07-27, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (12.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -1496.5%.
The range of the Relative Valuation is (12.78) - (12.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 23.8x - 30.1x | 27.0x |
| Fair Price | (12.78) - (12.49) | (12.09) |
| Upside | -1576.8% - -1543.3% | -1496.5% |
| Date | P/E |